Know Cancer

or
forgot password
  • cancer clinical trials in charlottesville, VA

  • Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Lung Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Prostate Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Lung Cancer
    Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Prostate Cancer
    Surgery in Treating Patients With Prostate Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Sarcoma
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Bladder Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Sarcoma
    Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    STI571 in Treating Patients With Recurrent Leukemia
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Prostate Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Ovarian Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Leukemia
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Colorectal Cancer
    BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Lung Cancer
    BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Pancreatic Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    University of Virginia
    Charlottesville, Virginia 22908
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
    University of Virginia
    Charlottesville, Virginia 22908
    Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer, Extensive Stage Small Cell Lung Cancer, Gastrointestinal Stromal Tumor, HER2-negative Breast Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Sarcoma, Ovarian Stromal Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Primary Liver Cancer, Recurrent Anal Cancer, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor, Recurrent Breast Cancer, Recurrent Cervical Cancer, Recurrent Colon Cancer, Recurrent Endometrial Carcinoma, Recurrent Esophageal Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Recurrent Gastric Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Pancreatic Cancer, Recurrent Prostate Cancer, Recurrent Rectal Cancer, Recurrent Salivary Gland Cancer, Recurrent Small Cell Lung Cancer, Recurrent Small Intestine Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Small Intestine Adenocarcinoma, Small Intestine Leiomyosarcoma, Small Intestine Lymphoma, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Anal Cancer, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor, Stage IV Breast Cancer, Stage IV Colon Cancer, Stage IV Endometrial Carcinoma, Stage IV Esophageal Cancer, Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IV Gastric Cancer, Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Stage IV Pancreatic Cancer, Stage IV Prostate Cancer, Stage IV Rectal Cancer, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer, Triple-negative Breast Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer
    Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma
    University of Virginia
    Charlottesville, Virginia 22908
    Non-Hodgkin's Lymphoma
    Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    University of Virginia Cancer Center

    Trial Locations
    University of Virginia Cancer Center
    Martha Jefferson Hospital Cancer Care Center
    Breast Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    University of Virginia Cancer Center

    Trial Locations
    University of Virginia Cancer Center
    Martha Jefferson Hospital Cancer Care Center
    Lymphoma
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Intraocular Melanoma, Melanoma (Skin)
    Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Intraocular Melanoma, Melanoma (Skin)
    Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Leukemia
    Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Lung Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer